SYK and COVID-19: Finally, we identified a key role for Fc receptor and complement signaling in platelet activation in COVID-19 because blockade of signaling through the FcγRIIa-Syk and the C5a-C5aR axis using antibody blockade, depletion of immunoglobulin from COVID-19 plasma or the FDA approved drug fostamatinib blocked activation of healthy platelets by COVID-19 plasma.